Goldman Sachs Resumes Amgen (AMGN) at Neutral
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Goldman Sachs resumes coverage on Amgen (NASDAQ: AMGN) with a Neutral. PT $91.00.
The firm comments, "AMGN's top line growth has slowed (0.3% in 2012-2015 vs. 5.5%
2009-2012) and we see a number of ongoing headwinds to AMGN's base businesses as we enter 2013."
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $90.17 yesterday.
The firm comments, "AMGN's top line growth has slowed (0.3% in 2012-2015 vs. 5.5%
2009-2012) and we see a number of ongoing headwinds to AMGN's base businesses as we enter 2013."
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $90.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
- Keefe, Bruyette & Woods Resumes Bank of Nova Scotia (BNS:CN) (BNS) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
